Market Cap 833.10M
Revenue (ttm) 84.28M
Net Income (ttm) -171.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -203.25%
Debt to Equity Ratio 1.47
Volume 1,144,900
Avg Vol 1,342,652
Day's Range N/A - N/A
Shares Out 99.30M
Stochastic %K 49%
Beta 0.86
Analysts Strong Sell
Price Target $25.60

Company Profile

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 858 771 9307
Address:
11682 El Camino Real, Suite 300, San Diego, United States
ae1213
ae1213 Apr. 8 at 12:58 PM
$SPRY $AQST aww … little silly sally is upset and it shows. How far up your ass did you reach to pull this “deep thought”? It is time to admit you bet in a wrong horse
0 · Reply
ThinkVision
ThinkVision Apr. 8 at 11:16 AM
$SPRY @howardlindzon another milestone https://www.globenewswire.com/news-release/2026/03/31/3265184/0/en/EURneffy-1-mg-approved-across-the-EU-as-the-first-and-only-needle-free-adrenaline-treatment-for-young-children-15-kg-at-risk-of-anaphylaxis.html
1 · Reply
BigGainTom
BigGainTom Apr. 7 at 9:04 PM
$SPRY Garbage. Looks like someone wants the $8 support to finally break.
0 · Reply
Stone52
Stone52 Apr. 7 at 2:16 PM
$SPRY Upcoming Catalysts: Canada Approval, Expanded Medicare Access from 7 states to entire US, Expanded Insurance Payer Access (Anthem Blue Cross), Uticaria study readout in Q3, Possible Buyout by ALK-Abello.
1 · Reply
Stone52
Stone52 Apr. 2 at 4:26 PM
$SPRY Another 4500 April 7.5 call purchased so far today. It represents 450,000 shares. With yesterday’s 2,000 calls, the buyer has purchased 6500 April 7.5 calls representing 650,000 shares
3 · Reply
Stone52
Stone52 Apr. 2 at 2:47 PM
$SPRY continuation from yesterday - another 500 April 7.5 calls purchased for $1.00. Represents another 50,000 shares
0 · Reply
Stone52
Stone52 Apr. 1 at 5:18 PM
$SPRY Now April 10 calls being purchased. Some big news may be coming in short order. Speaking of shorts - they could be caught with their pants down.
1 · Reply
Stone52
Stone52 Apr. 1 at 5:12 PM
$SPRY 2000 of the 7.5 April expry calls just purchased for $1.05. Highest call volume ever. Open interest was 249 calls. Buyer is betting the stock is above $8.55 by April 17th. Purchase represents 200,000 shares
0 · Reply
ae1213
ae1213 Apr. 1 at 5:04 PM
$AQST $SPRY you do realize that aqst has no chance to succeed, dont you? With their cash burn, tiny launch budget and approval (if any) in 12 months spry will leave no room for them and their gimmicky technology in the world wide market. Meanwhile spry will be sold within 12 months … can’t wait to see the acquisition price! Next 12 months will be continuous $AQST price decline to low 2s and some. Better sell here and buy $IOVA in 8 days below $2
4 · Reply
ae1213
ae1213 Apr. 1 at 4:26 PM
$SPRY aww little silly sally, just like a tiny dog barking at a bull, so funny … Institutional ownership here is 89%!
1 · Reply
Latest News on SPRY
Bad News For Competitor Turns Into Big Win For ARS Pharma Stock

Jan 9, 2026, 12:32 PM EST - 3 months ago

Bad News For Competitor Turns Into Big Win For ARS Pharma Stock


ae1213
ae1213 Apr. 8 at 12:58 PM
$SPRY $AQST aww … little silly sally is upset and it shows. How far up your ass did you reach to pull this “deep thought”? It is time to admit you bet in a wrong horse
0 · Reply
ThinkVision
ThinkVision Apr. 8 at 11:16 AM
$SPRY @howardlindzon another milestone https://www.globenewswire.com/news-release/2026/03/31/3265184/0/en/EURneffy-1-mg-approved-across-the-EU-as-the-first-and-only-needle-free-adrenaline-treatment-for-young-children-15-kg-at-risk-of-anaphylaxis.html
1 · Reply
BigGainTom
BigGainTom Apr. 7 at 9:04 PM
$SPRY Garbage. Looks like someone wants the $8 support to finally break.
0 · Reply
Stone52
Stone52 Apr. 7 at 2:16 PM
$SPRY Upcoming Catalysts: Canada Approval, Expanded Medicare Access from 7 states to entire US, Expanded Insurance Payer Access (Anthem Blue Cross), Uticaria study readout in Q3, Possible Buyout by ALK-Abello.
1 · Reply
Stone52
Stone52 Apr. 2 at 4:26 PM
$SPRY Another 4500 April 7.5 call purchased so far today. It represents 450,000 shares. With yesterday’s 2,000 calls, the buyer has purchased 6500 April 7.5 calls representing 650,000 shares
3 · Reply
Stone52
Stone52 Apr. 2 at 2:47 PM
$SPRY continuation from yesterday - another 500 April 7.5 calls purchased for $1.00. Represents another 50,000 shares
0 · Reply
Stone52
Stone52 Apr. 1 at 5:18 PM
$SPRY Now April 10 calls being purchased. Some big news may be coming in short order. Speaking of shorts - they could be caught with their pants down.
1 · Reply
Stone52
Stone52 Apr. 1 at 5:12 PM
$SPRY 2000 of the 7.5 April expry calls just purchased for $1.05. Highest call volume ever. Open interest was 249 calls. Buyer is betting the stock is above $8.55 by April 17th. Purchase represents 200,000 shares
0 · Reply
ae1213
ae1213 Apr. 1 at 5:04 PM
$AQST $SPRY you do realize that aqst has no chance to succeed, dont you? With their cash burn, tiny launch budget and approval (if any) in 12 months spry will leave no room for them and their gimmicky technology in the world wide market. Meanwhile spry will be sold within 12 months … can’t wait to see the acquisition price! Next 12 months will be continuous $AQST price decline to low 2s and some. Better sell here and buy $IOVA in 8 days below $2
4 · Reply
ae1213
ae1213 Apr. 1 at 4:26 PM
$SPRY aww little silly sally, just like a tiny dog barking at a bull, so funny … Institutional ownership here is 89%!
1 · Reply
BigGainTom
BigGainTom Apr. 1 at 3:06 PM
$SPRY Institutional ownership dropped about 10% in one month.
0 · Reply
BigGainTom
BigGainTom Mar. 30 at 5:53 PM
$SPRY Close at 7.62
0 · Reply
ThinkVision
ThinkVision Mar. 30 at 12:33 AM
0 · Reply
ThinkVision
ThinkVision Mar. 30 at 12:33 AM
0 · Reply
ThinkVision
ThinkVision Mar. 30 at 12:33 AM
$SPRY …..
0 · Reply
ThinkVision
ThinkVision Mar. 30 at 12:32 AM
$SPRY
0 · Reply
ThinkVision
ThinkVision Mar. 30 at 12:32 AM
0 · Reply
ThinkVision
ThinkVision Mar. 30 at 12:32 AM
0 · Reply
ThinkVision
ThinkVision Mar. 30 at 12:31 AM
0 · Reply
ThinkVision
ThinkVision Mar. 30 at 12:31 AM
0 · Reply
BigGainTom
BigGainTom Mar. 27 at 6:33 PM
$SPRY That drop could have been an options play for puts. They hammered it hard.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 27 at 6:00 PM
$SPRY RSI: 40.63, MACD: -0.3625 Vol: 0.49, MA20: 8.52, MA50: 9.32 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply